Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-18-000569

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +15,000 15,000 D
Loading xslF345X03/crisprfm4_jun152018.xml…